lenalidomide
Not Tagged
['lenalidomide', 'myeloid', 'dlbcl', 'mmsm', 'myeloma xi', 'mds', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)', 'cml', 'lymphoma', ' lena']
second primary malignancy in myeloma xi trial 4358 patients 5.5% spm in transplant-eligible (te) patients spm 12.2% @ 7yrs on len maintenance vs 5.8% no maint in te spm 17.1% @ 5yrs in tie on len maint vs 10%
#mmsm #ash22 
Washington U. School of Medicine.
Assoc Director Hem/Onc Fellowship.
Myeloma, Amyloidosis, Leukemia, Lymphoma & BMT physician and researcher.
Tweets are my own.